May-22-24 08:00AM
|
|
May-10-24 04:36PM
|
|
03:15PM
|
|
May-09-24 11:55AM
|
|
08:05AM
|
|
06:59AM |
Loading… |
06:59AM
|
|
May-03-24 04:30PM
|
|
May-02-24 08:00AM
|
|
Apr-04-24 04:30PM
|
|
Feb-29-24 08:41AM
|
|
Feb-28-24 09:49PM
|
(Thomson Reuters StreetEvents) +13.58% |
08:10AM
|
|
07:35AM
|
|
07:00AM
|
|
Feb-27-24 08:01AM
|
|
08:00AM |
Loading… |
Feb-21-24 08:00AM
|
|
Feb-20-24 10:00AM
|
|
Feb-01-24 08:00AM
|
|
Jan-05-24 08:01AM
|
|
Dec-01-23 04:30PM
|
|
Nov-08-23 02:42PM
|
|
12:13AM
|
(Thomson Reuters StreetEvents) |
Nov-07-23 08:10AM
|
|
07:00AM
|
|
Oct-31-23 04:30PM
|
|
08:00AM
|
|
Sep-07-23 06:30AM
|
(American City Business Journals) |
Sep-06-23 07:00AM
|
|
Aug-18-23 09:35AM
|
|
Aug-16-23 09:35AM
|
|
09:40AM |
Loading… |
Aug-08-23 09:40AM
|
|
08:00AM
|
|
Aug-04-23 04:05PM
|
|
Jul-28-23 10:13AM
|
|
03:14AM
|
|
Jul-27-23 09:34PM
|
|
01:44PM
|
(American City Business Journals) |
07:06AM
|
|
Jul-13-23 09:45AM
|
|
Jul-06-23 04:05PM
|
|
Jun-22-23 11:04AM
|
|
Jun-16-23 10:43AM
|
|
02:26AM
|
|
Jun-15-23 09:32AM
|
|
07:36AM
|
|
07:30AM
|
|
Jun-13-23 06:00AM
|
|
Jun-02-23 04:05PM
|
|
May-28-23 09:06AM
|
|
May-24-23 08:00AM
|
|
May-09-23 08:35AM
|
|
07:00AM
|
|
May-04-23 04:05PM
|
|
May-03-23 08:00AM
|
|
May-02-23 08:00AM
|
|
Apr-26-23 04:05PM
|
|
Apr-19-23 02:42PM
|
|
Apr-17-23 11:07AM
|
|
Apr-06-23 04:05PM
|
|
Apr-05-23 02:00PM
|
|
Mar-16-23 11:20AM
|
|
Mar-13-23 02:00PM
|
|
07:54AM
|
|
07:30AM
|
|
Mar-10-23 07:10PM
|
|
Mar-03-23 04:05PM
|
|
Mar-02-23 08:55PM
|
|
Mar-01-23 05:24AM
|
|
Feb-28-23 11:51PM
|
(Thomson Reuters StreetEvents) +11.60% |
07:00AM
|
|
Feb-21-23 08:00AM
|
|
Feb-03-23 04:05PM
|
|
Feb-02-23 08:00AM
|
|
Feb-01-23 08:00AM
|
|
Jan-25-23 08:00AM
|
|
Jan-20-23 03:16PM
|
|
Jan-16-23 02:18AM
|
|
Jan-06-23 04:05PM
|
|
07:00AM
|
|
Dec-31-22 07:42AM
|
|
Dec-23-22 12:46PM
|
(American City Business Journals) |
10:08AM
|
|
Dec-22-22 04:08PM
|
|
04:05PM
|
|
Dec-14-22 08:00AM
|
|
Dec-02-22 04:05PM
|
|
Nov-08-22 08:00AM
|
|
Nov-07-22 08:25AM
|
|
07:00AM
|
|
Nov-04-22 04:05PM
|
|
Oct-31-22 08:00AM
|
|
Oct-30-22 10:13AM
|
|
Oct-17-22 09:40AM
|
|
Oct-06-22 04:05PM
|
|
Oct-04-22 04:05PM
|
|
Sep-30-22 08:02AM
|
|
Sep-12-22 08:00AM
|
|
Sep-06-22 08:00AM
|
|
Sep-02-22 04:05PM
|
|
Sep-01-22 10:17AM
|
|
|
|
|
Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of antibody-drug conjugates that offer clinical benefit for cancer patients. Its product candidates are Upifitamab Rilsodotin (UpRi), XMT-1536, and XMT-1592. The company was founded by Mikhail Papisov in 2001 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Protopapas Anna | Director | Jan 16 '24 | Sale | 2.71 | 29,399 | 79,671 | 125,153 | Jan 17 05:21 PM | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Jan 16 '24 | Sale | 2.71 | 10,409 | 28,208 | 199,329 | Jan 17 05:19 PM | DeSchuytner Brian | SVP, COO & CFO | Jan 16 '24 | Sale | 2.71 | 9,327 | 25,276 | 54,511 | Jan 17 05:18 PM | Mandelia Ashish | VP, Chief Accounting Officer | Jan 16 '24 | Sale | 2.71 | 5,025 | 13,618 | 23,328 | Jan 17 05:20 PM | Carvajal Alejandra | SVP, Chief Legal Officer | Jan 16 '24 | Sale | 2.71 | 4,381 | 11,873 | 27,403 | Jan 17 05:18 PM | Bala Mohan | SVP, Chief Development Officer | Jan 16 '24 | Sale | 2.71 | 3,431 | 9,298 | 14,052 | Jan 17 05:16 PM | MISRA TUSHAR | SVP, Chief Manuf. Officer | Jan 16 '24 | Sale | 2.71 | 3,357 | 9,097 | 17,966 | Jan 17 05:21 PM | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Jan 15 '24 | Option Exercise | 0.00 | 15,208 | 0 | 209,738 | Jan 17 05:19 PM | DeSchuytner Brian | SVP, COO & CFO | Jan 15 '24 | Option Exercise | 0.00 | 10,208 | 0 | 63,838 | Jan 17 05:18 PM | Protopapas Anna | Director | Jan 15 '24 | Option Exercise | 0.00 | 38,958 | 0 | 154,552 | Jan 17 05:21 PM | Mandelia Ashish | VP, Chief Accounting Officer | Jan 15 '24 | Option Exercise | 0.00 | 5,352 | 0 | 28,353 | Jan 17 05:20 PM | Mandelia Ashish | VP, Chief Accounting Officer | Jan 14 '24 | Option Exercise | 0.00 | 4,783 | 0 | 23,001 | Jan 17 05:20 PM | MISRA TUSHAR | SVP, Chief Manuf. Officer | Jan 14 '24 | Option Exercise | 0.00 | 1,458 | 0 | 21,323 | Jan 17 05:21 PM | Protopapas Anna | Director | Jan 14 '24 | Option Exercise | 0.00 | 16,750 | 0 | 115,594 | Jan 17 05:21 PM | Carvajal Alejandra | SVP, Chief Legal Officer | Jan 14 '24 | Option Exercise | 0.00 | 2,500 | 0 | 31,784 | Jan 17 05:18 PM | DeSchuytner Brian | SVP, COO & CFO | Jan 14 '24 | Option Exercise | 0.00 | 6,250 | 0 | 55,630 | Jan 17 05:18 PM | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Jan 14 '24 | Option Exercise | 0.00 | 4,792 | 0 | 194,530 | Jan 17 05:19 PM | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | Jan 13 '24 | Option Exercise | 0.00 | 9,375 | 0 | 189,738 | Jan 17 05:19 PM | DeSchuytner Brian | SVP, COO & CFO | Jan 13 '24 | Option Exercise | 0.00 | 10,000 | 0 | 47,380 | Jan 17 05:18 PM | Carvajal Alejandra | SVP, Chief Legal Officer | Jan 13 '24 | Option Exercise | 0.00 | 8,958 | 0 | 29,284 | Jan 17 05:18 PM | Bala Mohan | SVP, Chief Development Officer | Jan 13 '24 | Option Exercise | 0.00 | 8,750 | 0 | 17,483 | Jan 17 05:16 PM | Protopapas Anna | Director | Jan 13 '24 | Option Exercise | 0.00 | 31,250 | 0 | 98,844 | Jan 17 05:21 PM | MISRA TUSHAR | SVP, Chief Manuf. Officer | Jan 13 '24 | Option Exercise | 0.00 | 7,083 | 0 | 19,865 | Jan 17 05:21 PM | Mandelia Ashish | VP, Chief Accounting Officer | Jan 13 '24 | Option Exercise | 0.00 | 2,645 | 0 | 18,218 | Jan 17 05:20 PM | Bala Mohan | SVP, Chief Development Officer | Oct 26 '23 | Sale | 1.13 | 1,912 | 2,161 | 8,733 | Oct 27 04:07 PM | Bala Mohan | SVP, Chief Development Officer | Oct 25 '23 | Option Exercise | 0.00 | 6,250 | 0 | 10,645 | Oct 27 04:07 PM | MISRA TUSHAR | SVP, Chief Manuf. Officer | Aug 17 '23 | Sale | 1.18 | 1,908 | 2,251 | 11,507 | Aug 18 04:01 PM | MISRA TUSHAR | SVP, Chief Manuf. Officer | Aug 16 '23 | Option Exercise | 0.00 | 6,250 | 0 | 13,415 | Aug 18 04:01 PM |
|